Skip to content

Altss / Company outcomes

Accolade logo

Accolade

United StatesHealthtechSale / transferCompany website ↗

Accolade is listed in the company outcomes register under sale / transfer. This historical record includes a dated benchmark and company identity sources.

Company reference / Source snapshot Oct 23, 2026

The category and benchmark below reflect the dated company record. They have not received the independent financial investigation required for an Altss research case.

Identity and known-contradiction screen recorded Oct 26, 2026. The source snapshot is not the event date.

Historical benchmark

~$3.5bn

Source-reported benchmark year: 2021 · Nominal US dollars, rounded

The source note ties the approximate benchmark amount to a historical public-market or IPO valuation. Its underlying financial source was not independently rechecked, and the amount is not a current market capitalization.

Basis: Public market benchmark (source-indicated). The dataset mixes private financing, SPAC transaction values and public market capitalization.

Recorded classification

Sale / transfer

Record snapshot .

This is a source classification, not an independently verified Altss event or an assertion of present value or solvency.

This source-reported figure does not independently establish a private unicorn valuation, a verified peak or current value. Different valuation bases cannot be subtracted to calculate investor losses.

Company identity

Accolade is identified through its linked official company website. The source describes a public-market benchmark; it is not a private funding-round valuation or a current market capitalization.

Accolade — company website ↗

Identity evidence · Accessed Oct 26, 2026

Country and sector are normalized dataset classifications. A brand or website may continue under a new owner; its availability does not verify the financial benchmark.

Logo: Accolade logo source. Company trademark rights remain.